IO Biotech Incorporated is a biopharma company developing immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103 is in clinical trials to treat melanoma, as well as lung, bladder, and head and neck cancers. IO Biotech was incorporated in 2014 and is headquartered in Copenhagen, Denmark.
What is Io Biotech's quote symbol?
What is the 52 week high and low for Io Biotech (NASDAQ: IOBT)?
How much is Io Biotech stock worth today?
How much is Io Biotech's stock price per share?
What is Io Biotech's Market Cap?